|Day Low/High||79.27 / 80.13|
|52 Wk Low/High||52.83 / 80.19|
Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the pivotal Phase 3 KEYNOTE-407 trial investigating KEYTRUDA ® (pembrolizumab), Merck's anti-PD-1 therapy, in combination with carboplatin-paclitaxel or...
Stocks were mixed on Tuesday with investors adopting a cautious stance as the Federal Reserve begins a two-day meeting.
Let's take a look at the charts and indicators to see what may lie ahead for this drug maker.
U.S. stock futures are mixed as the Federal Reserve kicks off a two-day meeting and Apple is scheduled to report quarterly results.
Global stocks bumped higher Tuesday, while oil prices held at three-and-a-half year highs, amid several key market closures and ahead of what could be a crucial quarterly earnings update from Apple after the close of trading.
I think it very possible that there will be a positive reaction tonight, more likely based on what Tim Cook says.
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced financial results for the first quarter of 2018.
Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.
Jim Cramer says foolish traders believe a trade war will trigger a recession, but they're wrong. Fight the crosswinds with a game plan for next week.
The drugmakers and health insurer are preparing to unveil first-quarter numbers.
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that following validation by the European Medicines Agency (EMA), the centralized review process has begun for the company's Type II Variation, which seeks approval for...
Procter & Gamble, which is buying the Merck unit, was previously reported to be in talks to acquire Pfizer's consumer healthcare business.
Asia markets traded mostly lower Tuesday, with Hong Kong's benchmark down almost 500 points.
Stocks rise Monday as concerns over prolonged military action in Syria fade and the focus for investors shifts to a heavy upcoming slate of U.S. corporate earnings.
Data and industry conferences will likely be catalysts for shares in the space.
Legendary investor Jim Rogers thinks the market is headed straight for a major sell off. Here's why.
Today, Jim discusses Raytheon, tensions in Syria, bank earnings, Kohl's, Nordstrom and more!
The drugmakers on April 16 released data from their respective studies at the Association for Cancer Research's annual meeting in Chicago.
The Trump Administration cut corporate taxes and U.S. Senator Cory Booker hoped pharma companies would cut drug prices. That didn't happen and Booker's new analysis hammers those drug companies.
Stocks rise Monday following tweets from Donald Trump that appeared to indicate the U.S. was softening its approach in its trade battle with China.
Markets around the globe last week were tumultuous after both China and the U.S. proposed tariffs on imported goods as investors weigh whether the countries will come to the table to negotiate an end to the spat.
Incyte Corporation (Nasdaq:INCY) and Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that an external Data Monitoring Committee (eDMC) review of the pivotal Phase 3 ECHO-301/KEYNOTE-252...
AstraZeneca and Merck (NYSE:MRK), known as MSD outside the US and Canada, today announced that the European Medicines Agency has validated for review the Marketing Authorization Application (MAA) for LYNPARZA ®...
Merck (NYSE:MRK), known as MSD outside the United States and Canada, will hold its first-quarter 2018 sales and earnings conference call with institutional investors and analysts at 8:00 a.
The basic features of a prosperous corporate environment are all around us, but it's become difficult to stick to that narrative amid all the diversions, including from the President.
A study of analyst recommendations at the major brokerages shows that Merck & Co Inc is the #12 broker pick, on average, out of the 30 stocks making up the Dow Jones Industrial Average, according to ETF Channel. Merck & Co Inc also comes in above the median of analyst picks among the broader S&P 500 index components, claiming the #187 spot out of 500.
Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the appointment of Jennifer Zachary as general counsel, effective April 16, 2018.
Watch for these upstart names to topple some big-caps going forward.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.